JUDY RIEKER: Open Payments
NPI 1710985874 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,107 in 50 payments from 15 companies in 2025. Trend: 2023 $236 · 2024 $107 · 2025 $2,107
Food & beverage: $2,107
| Company | Payments | Amount |
|---|---|---|
| AOP Health US, LLC | 1 | $967 |
| Novartis Pharmaceuticals Corporation | 22 | $249 |
| BridgeBio Pharma, Inc. | 6 | $202 |
| AstraZeneca Pharmaceuticals LP | 3 | $185 |
| Amgen Inc. | 3 | $146 |
| Boston Scientific Corporation | 2 | $114 |
| SCPHARMACEUTICALS INC. | 4 | $71 |
| ABBVIE INC. | 1 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $29 |
| Baxter Healthcare | 1 | $26 |
Products named: Rapiblyk, LEQVIO, Attruby, LOKELMA, REPATHA, General - Therapies, FUROSCIX, QULIPTA.
Industry payments across NY — which companies pay providers there.
